查詢結果分析
相關文獻
- Risk of Ocular Complications Following Radiation Therapy in Head and Neck Cancer Patients: A Nationwide Retrospective Population-based Cohort Study
- A Planning Study for Feasibility of Applying Volumetric-Modulated Arc Therapy for Locally Advanced Head and Neck Cancer
- 輔助性中醫治療對於接受放射及化學治療之頭頸癌住院病人之效益
- 挽救性手術後再次輔助性放射治療於復發性頭頸部鱗狀上皮細胞癌患者之適用性
- Impact of Comorbidity on Survival for Locally Advanced Head and Neck Cancer Patients Treated by Radiotherapy or Radiotherapy Plus Chemotherapy
- 輔助性中醫治療對於接受放射及化學治療之頭頸癌住院病人之效益
- 頭頸癌病患放射治療合併頭頸部出血的處置
- Comparison of Acute Toxicities and Treatment Tolerance between Tri-Weekly High-Dose and Weekly Low-Dose Cisplatin during Concurrent Chemoradiotherapy for Head and Neck Cancer Patients
- Pretreatment Lymphocyte Count as Prognostic Factor in Patients with Head-and-Neck Cancer
- 頭頸癌病人放射治療毒性反應預測因素之研究
頁籤選單縮合
題 名 | Risk of Ocular Complications Following Radiation Therapy in Head and Neck Cancer Patients: A Nationwide Retrospective Population-based Cohort Study=頭頸癌病患接受放射治療產生眼睛併發症的風險:臺灣健保資料庫研究 |
---|---|
作 者 | 曹志鉦; 劉珉玥; 羅承翔; 范兆岳; 黃文彥; 趙興隆; 陳昌明; 楊仁富; 沈伯鍵; 林昆澤; 林群書; 趙興隆; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 24:3 2017.09[民106.09] |
頁 次 | 頁197-205 |
分類號 | 416.21 |
關鍵詞 | 眼睛併發症; 放射治療; 頭頸癌; 健保資料庫; Ocular complications; Radiation therapy; Head and neck cancer; National Health Insurance Research Database; |
語 文 | 英文(English) |
中文摘要 | 目的:探討頭頸癌病患接受放射治療產生眼睛併發症的風險。材料與方法:本研究從 1997 年至 2010 年自台灣健保資料庫中,找出頭頸癌接受放射治療病人共 2,733 位,未接受放射治療病人共 375 位。追蹤停止時間為發生眼睛併發症(白內障、青光眼、視網膜病變)或 2010 年 12 月 31 日。結果:校正可能影響結果的因子後,頭頸癌接受放射治療病人比未接受放射治療病人產生眼睛併發症的風險為 2.45 倍(HR; 2.451, 95% CI = 1.087-6.895)。當追蹤時間超過 36 個月,頭頸癌接受放射治療病人比未接受放射治療病人產生眼睛併發症的風險為 2.581 倍(adjusted HR =2.581, 95% CI = 1.256-5.493)。頭頸癌原發部位以鼻咽癌和口腔癌居多;產生的眼睛併發症以視網膜病變和白內障居多。結論:在台灣的頭頸癌病人,放射治療與之後產生的眼睛併發症兩者有相關聯性;放射腫瘤科醫師對此相關聯性要提高警覺。 |
英文摘要 | Purpose : To examine the risk of ocular complications following radiotherapy in head and neck cancer patients. Materials and Methods : We identified a radiotherapy cohort (n= 2,733) and a control cohort (n= 375) in the National Health Insurance Research Database from 1997 to 2010. The follow-up period was terminated upon developing ocular complications (ICD-9-CM 361, 362, 363, 365, 366) or on December 31, 2010. Results : After adjusting for the confounding factors of the study, the radiotherapy cohort had a higher adjusted hazard ratio (HR; 2.451, 95% CI = 1.087-6.895) of developing ocular complications than did the control cohort. The radiotherapy cohort was associated with a significantly higher risk of developing ocular complications compared with the control cohort when the follow-up period was longer than 36 months (adjusted HR = 2.581, 95% CI = 1.256-5.493). Primary head and neck tumors are mostly located in the nasopharynx and oral cavity. The most common associated ocular complications were retinopathy and cataracts. Conclusions : Patients who receive radiotherapy for head and neck cancer might be at higher risk for developing ocular complications in Taiwan. Radiation oncologists should pay more attention to this association. |
本系統中英文摘要資訊取自各篇刊載內容。